Insider Transactions in Q2 2021 at Elevation Oncology, Inc. (ELEV)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Open market or private purchase
|
Direct |
625,000
+19.33%
|
$10,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Ven Bio Global Strategic Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
1,983,167
+50.0%
|
-
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Open market or private purchase
|
Direct |
187,500
+6.2%
|
$3,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Aisling Capital Iv, LP |
BUY
Conversion of derivative security
|
Direct |
2,351,592
+30.57%
|
-
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+11.65%
|
$5,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+10.07%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,983,168
+50.0%
|
-
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+9.77%
|
$4,000,000
$16.0 P/Share
|
|
Jun 29
2021
|
Vertex Global Hc Fund Ii Pte. Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,057,642
+33.16%
|
-
|